Skip to main content

Table 2 Alpha defensin levels according to clinical manifestations of systemic sclerosis

From: Serum defensin levels in patients with systemic sclerosis

Clinical manifestations No involvement Involvement present P values
Interstitial lung disease 430 [140–595] (n = 22) 684 [324–1152] (n = 20) 0.04*
Pulmonary hypertension 503 [139–888] (n = 31) 624 [300–991] (n = 11) 0.4
Raynaud’s phenomenon 512 (n = 1) 564 [157–890] (n = 41) 0.95
Telangiectasia 621 [388–894] (n = 22) 498 [135–879] (n = 20) 0.29
Digital Ulcer 583 [165–938] (n = 26) 529 [164–813] (n = 16) 0.56
Esophageal Involvement 588 [352–890] (n = 29) 506 [124–933] (n = 13) 0.34
  1. Values represent median with 25–75 percentiles in square brackets and the number of patients in parentheses
  2. *p value <0,05